Organization type
- Foundation
Early phases
- Biomarker identification
- Omics
- Target identification – new biological hypothesis
- Target validation – Hypothesis verification
Screening
- Assay development
- Chemical libraries
- Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)
Optimization phases
- In vitro biochemical models(including assay/model development and testing)
- In vitro cellular and organotypic 3D models (including assay/model development and testing)
- Mechanism of action (MoA) assessment
- Medicinal chemistry programs for hit to lead and lead optimization
Functional areas
- Molecular and cellular biology
Terapeutic areas
- Autoimmunity / Inflammation
- Blood and lymphatic system
- Cancer
- Cardiovascular
- Dermatology
- Infectious diseases
- Nervous Central System
- Ophthalmology / Optometry
- Rare diseases
Additional activities
- Consulting services